10/5/2009 Margaret Biancofiori, SRNA Rosalind Franklin University of Medicine and Science October 4, 2009 What is P.O.T.S.? Chronic form of orthostatic intolerance syndrome Primarily affects younger women -but not exclusively (4:1) Definition: Symptoms of orthostatic intolerance accompanied by a heart rate increase of at least 30BPM or a rate that exceeds 120 BMP that occurs within the first 10 min. of standing or head –up tilt Signs and symptoms of OI/P.O.T.S. Dramatic increase in HR associated with one or more of the following: Light-headedness Clouded thoughts Blurring/dimming vision Anxiety Shoulder / Neck pain Nausea Diaphoresis Frank syncope 1 10/5/2009 Defining Orthostatic Intolerance Provocation of symptoms upon standing and relief of symptoms when becoming supine-although symptoms can present without change in position OI is synonymous with: Idiopathic orthostatic intolerance Postural orthostatic tachycardia syndrome Orthostatic tachycardia syndrome Sympathetic orthostatic hypotension Hyperadrenergic postural hypotension Idiopathic hypovolemia Mitral valve prolapse syndrome Soldier’s Heart Irritable Heart Chronic Fatigue Syndrome Orthostatic Intolerance According to the Vanderbilt Autonomic Dysfunction Center at Vanderbilt University Medical Center, Other than essential hypertension, OI is the most common disorder of blood pressure regulation. OI is also the most frequently encountered dysautonomia. Nearly 500,000 Americans are affected ranging from mild to debilitating. Diabetes is one of the most significant secondary causes of Orthostatic hypotension Pathophysiology Poorly characterized Pts often have elevated levels of catecholamines with standing (“hyperadrenergic state”) Baseline hypovolemia Excessive pooling of blood in lower extremities with standing w/ an exaggerated orthostatic hypovolemia Evidence of lower extremity sympathetic denervation 2 10/5/2009 Pathophysiology2 Sub-types 1) Partial Dysautonomia- 90% of cases Presents as tachycardia w/light-headedness,nausea, chronic fatigue, dependent edema, acrocyanosis 2)Hyperadrenergic (<10%) Manifests as increased serum Norepinepherine (>600pg/ml) (Normal 150-550 pg/ml),tremulousness, anxiety and exaggerated response to B-adrenergic stimulation Diagnosis Tilt table test Standard method-reverse T-burg tilt of at least 60 degrees Optimal duration is 40 minutes with periodic measurements of HR and BP. Test is concluded upon syncopal episode Isoproterenol maybe injected IV to test for hypersensitivityof betaadrenergic receptors. People who have POTS with beta-receptor supersensitivity and a hyperadrenergic state will have an exacerbation of symptoms from isoproterenol. Otherdrugs used in place of isoproterenol include nitroglycerin, edrophonium,adenosine triphosphate, ephedrine and nitroprusside Symptoms of orthostatic intolerance accompaniedbya heart rate increase of at least 30BPM or a rate that exceeds 120 BMP that occurs within the first 10 min. of standing or head –up tilt Tilt Table Test www.nymc.edu/fhp/ centers/syncope/ HUT%20and...ation.htm 3 10/5/2009 Diagnosis Catecholamine level and metabolite measurements via blood test or 24 hr urine collection Bowel motility studies Cold pressor test MRI to detect brain lesions EMG/nerve conduction studies Treatments-Pharmacologic MIDODRINE: (Proamatine) Alpha-1 agonist Pro-drug ; converted to active compound desglymidodrine Parent compound peaks 30 min. after PO dose Active compound peaks 1-2 hrs after PO dose Elimination T ½ is 3-4 hours Pro-drug and metabolite excreted in urine Dose 2.5-10 mg 3x day MOA: Increases BP via increase in peripheral vascular resistance No direct effect on heart-may see reflex decrease in HR Manypatients take Beta blockers to counteract reflex tachycardia associated with OI/OH Treatments (cont’d) Midodrine Side effects: piloerection, pruritus, tingling of scalp Supine hypertension is a side effect of greater concern with BPs of > 180/110 mmHg in 25% of pts taking Midodrine 3x daily Pts are advised to take evening dose 4hrs before bedtime to decrease nocturnal supine hypertension Pts are also advised to elevate the head of the bed 30 degrees to further decrease the possibility of supine hypertension 4 10/5/2009 Treatments Beta-blocker therapy: Propranolol 20 mg 2x day Fludrocortisone (Florinef) 0.1 -0.4mg daily Potent mineralocorticoid properties Causes sodium/water retention May need to replace potassium – check pts potassium level DIET: Increased fluid consumption along with increased sodium potassium intake is recommended to maintain volume/BP. Compression stockings are sometimes indicated. Anesthetic Implications Thorough preoperative H&P to determine the major pathophysiologic component Correction of hypovolemia-HYDRATE Adequate pre-op anxiolysis to decrease sympathetic response/tachycardia A-line and/or CVP Be mindful that use of alpha-1 agonists such as phenylepherine may be useful to treat hypotension but that lower extremity sympathetic denervation may cause upregulation of peripheral alpha-1 receptors leading to receptor hypersensitivity Anesthetic Implications Supine hypertension: Many OI patients exhibit hypertension when supine Thought to be due to lack of baroreceptor control and/or hypersensitivity of partially denervated postsynaptic adrenoreceptors to NE According to a study by Chaimberg and Travis, pts taking Midodrine may exhibit severe hypertension when supine. They advise patients to omit their midodrine on the day of surgeryespecially of prolonged post-op bedrest is anticipated. Reverse Trendellenburg as a treatment if possible-it’s effect is quick and readily reversible 5 10/5/2009 Anesthetic ImplicationsLabor and Delivery Goals: Avoid stress of labor and subsequent tachycardic response P.O.T.S. is associated with hemodynamic instability This HD instability is worsened by labor and delivery HD instability can be lessened w/ early pain control Neuraxial blockade may need to be in lateral decubitus position as sitting may exacerbate P.O.T.S. symptoms Monitor BP q 1-2 minutes Anesthetic ImplicationsLabor and Delivery 2nd stage of labor is greatest concern Management varies with patient’s response to Valsalva maneuver P.O.T.S. pts have larger decrease in BP in early phase of Valsalva and larger overshoot of BP and HR in late phase Slower return to baseline Decreased thoracic blood flow Significant increase in pelvic vascular resistance during Valsalva found in non-pregnant patients with increase in syncopal events No studies yet in pregnant patients but combination of the HD changes is thought to greatlycompromise uteroplacental blood flow Anesthetic ImplicationsLabor and Delivery Recommendations from a study conducted by McEvoy, Low and Hebbar;2007: A-line if large HD changes noted in 2nd stage of labor If variations sustained and baseline values not reached before next contraction -or- If baby not tolerating pushing Restrict Valsalva maneuvers and proceed with instrumental or operative delivery If C-section delivery with neuraxial blockade: Epidural is method of choice : Ability to incrementally dose epidural produces gradual change in HD rather than the suddendecrease in systemic vascular resistance and subsequent increase in baroreceptor activated sympathetic activity observed with SAB. (Corbett, et.al.;2006) 6 10/5/2009 Anesthetic ImplicationsLabor and Delivery HTN in P.O.T.S. pts with hyperadrenergic form: Labetalol is ok but unpredictable- McEvoy, et.al., recommend smaller doses, titrated to effect Hypotension associated with neuraxial blockade Phenylepherine drug of choice in pts with hyperadrenergic form of P.O.T.s. – thought to be more beneficial to increase BP via vasoconstrictive , alpha-1 response rather than increase in HR PRE-HYDRATE Team approach with anesthesia, obstetrics and neurology and early consultation is recommened in parturients with P.O.T.S. Outlook More research needed- At the time of the study by Corbett, et.al. , only two studies had previously been reported on epidural management for patients undergoing cesarean section. Places conducting research: Vanderbilt Autonomic Dysfunction Center Nashville, TN www.mc.vanderbilt.edu National Dysautonomia Research Foundation Red Wing, MN www.ndrf.org Center for Hypotension New York Medical College Valhalla, New York www.nymc.edu/fhp/centers/syncope/J_Stewart.htm References Chaimberg K,Travis K. Supine Hypertension During GeneralAnesthesia in a Patient Taking Midodrine: Anesthesia&Analgesia 2002;95: 1196-1197. http://www.anesthesiaanalgesia.org/cgi/content/full/95/5/1196 Accessed July 2,2009. Corbett WL, ReiterCM,Schultz JR, Kanter RJ, Habib AS.Anaesthetic management of a parturient with the postural orthostatic tachycardia syndrome: a case report: British Journal ofAnaesthesia 2006;97: 196-199. http://bja.oxfordjournals.org/cgi/content/full/97/2/196 Accessed December 29, 2008. McEvoy MD, Low PA, Hebbar L. PosturalOrthostatic Tachycardia Syndrome: Anesthetic Implications in theObstetric Patient: Anesthesia&Analgesia 2007;104: 166-167. http://anesthesia-analgesia.org/cgi/content/full/104/1/166 Accessed July 20, 2009. Mchaourab A, Mazzeo A, May J, Pagel P. PerioperativeConsiderations in a Patient with Orthostatic IntoleranceSyndrome; Anesthesiology 2000;93: 571-573. http://journals.1ww.com/anesthesiology/pages/articleviewer.aspx?year=2000&issue=0800... Accessed December 29, 2008. Vanderbilt Autonomic Dysfunction CenterWebsite. http://www.mc.vanderbilt.edu/root/vumc.php?site=adc&doc=4783 Accessed September 29, 2009. 7
© Copyright 2024